Doctor profile · Federal record
Dr. Chao Yin, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Fairfax, VA
- NPI 1477909240
- Accepts Medicare
- MIPS 89.8 / 100 · 2023
- 10 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
8613 Route 29 # 200N
Fairfax, VA 220312171
(571) 350-8400
fax (703) 280-9596 - Mailing address
-
3040 Williams Dr Ste 100
Fairfax, VA 220314618
Credentials & registration
- NPI registered
- May 2016 — 10 yrs on file
- Profile last updated
- April 24, 2024
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Virginia #0101265952
- Medicaid
- VA #1477909240
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477909240. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
96,138
Distinct HCPCS
10
Medicare allowed
$1,461,666
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 27,000 | 30 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15,260 | 37 | $3 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,040 | 31 | $47 | |
J9025 |
Injection, azacitidine, 1 mg | 8,100 | 11 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,690 | 20 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 6,500 | 12 | $54 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 5,710 | 11 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,570 | 17 | $28 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,460 | 79 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 1,430 | 11 | $2 |
In context: peer comparison
Among 7 peers in Fairfax Hematology & Oncology Physician, average services per provider: 1,248. This provider delivers 77× the peer median.Open Payments
Industry payments received
All-time total
$2,304
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 3 | $554.68 | |
| Janssen Biotech, INC. | 9 | $268.28 | |
| Novartis Pharmaceuticals Corporation | 9 | $199.46 | |
| Daiichi Sankyo INC. | 12 | $157.98 | |
| Myriad Genetic Laboratories, INC. | 1 | $130.04 | |
| Abbvie INC. | 4 | $118.55 | |
| Gilead Sciences, INC. | 3 | $79.61 | |
| Celgene Corporation | 3 | $69.42 | |
| Takeda Pharmaceuticals U.S.A., INC. | 3 | $63.75 | |
| Genentech USA, INC. | 2 | $56.16 | |
| Alexion Pharmaceuticals, INC. | 2 | $48.02 | |
| Eisai INC. | 2 | $47.51 | |
| Pfizer INC. | 3 | $47.36 | |
| Bioprotect Medical, INC. | 1 | $45.50 | |
| Servier Pharmaceuticals LLC | 2 | $45.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
284
Patients
28
Total drug cost
$548,010
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 48 | 12 | $32,583 |
| Dexamethasone | Generic | 40 | 16 | $807 |
| Xarelto (Rivaroxaban) | Brand | 36 | 0 | $20,731 |
| Lenalidomide | Generic | 23 | 0 | $253,355 |
| Acyclovir | Generic | 20 | 0 | $420 |
| Anastrozole | Generic | 17 | 0 | $940 |
| Ibrance (Palbociclib) | Brand | 14 | 0 | $237,476 |
| Levofloxacin | Generic | 14 | 0 | $853 |
| Prednisone | Generic | 14 | 0 | $61 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 12 | 0 | $290 |
Hospital affiliations
Frequently asked questions
What is Dr. Chao Yin's medical specialty?
Dr. Chao Yin practices Hematology & Oncology Physician in Fairfax, VA.
Where does Dr. Chao Yin practice?
Dr. Chao Yin practices at 8613 Route 29 # 200N, Fairfax, VA 220312171. Office phone: 5713508400.
What is Dr. Chao Yin's NPI?
Dr. Chao Yin's National Provider Identifier (NPI) is 1477909240, issued by NPPES.
Does Dr. Chao Yin accept Medicare assignment?
Yes. Dr. Chao Yin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Chao Yin commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.